Literature DB >> 27010034

Regulating VEGF signaling in platelet concentrates via specific VEGF sequestering.

David G Belair1, Ngoc Nhi Le, William L Murphy.   

Abstract

Platelets contain an abundance of growth factors that mimic the composition of the wound healing milieu, and platelet-derived VEGF in particular can negatively influence wound healing if unregulated. Here, we sought to capture and regulate the activity of VEGF factor from human platelets using poly(ethylene glycol) microspheres. In this communication, we demonstrate that platelet freeze/thaw produced significantly higher levels of Vascular Endothelial Growth Factor (VEGF) than either calcium chloride treatment, protease activated receptor 1 activating peptide (PAR1AP) treatment, or thrombin treatment. PEG microspheres containing a VEGF-binding peptide (VBP), derived from VEGFR2, sequestered VEGF from platelet concentrate, prepared via freeze/thaw, and reduced the bioactivity of platelet concentrate in HUVEC culture, which suggests that VBP microspheres sequestered and reduced the activity of VEGF from patient-derived platelets. Here, we demonstrate the ability of VEGF sequestering microspheres to regulate the activity of VEGF derived from a growth factor-rich autologous human blood product.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27010034      PMCID: PMC4846557          DOI: 10.1039/c5bm00633c

Source DB:  PubMed          Journal:  Biomater Sci        ISSN: 2047-4830            Impact factor:   6.843


  32 in total

1.  Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells.

Authors:  N Ferrara; W J Henzel
Journal:  Biochem Biophys Res Commun       Date:  1989-06-15       Impact factor: 3.575

2.  Specific VEGF sequestering and release using peptide-functionalized hydrogel microspheres.

Authors:  Nicholas A Impellitteri; Michael W Toepke; Sheeny K Lan Levengood; William L Murphy
Journal:  Biomaterials       Date:  2012-02-07       Impact factor: 12.479

Review 3.  The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature.

Authors:  J Alsousou; M Thompson; P Hulley; A Noble; K Willett
Journal:  J Bone Joint Surg Br       Date:  2009-08

4.  Specific VEGF sequestering to biomaterials: influence of serum stability.

Authors:  David G Belair; William L Murphy
Journal:  Acta Biomater       Date:  2013-06-29       Impact factor: 8.947

5.  The effect of P2Y-mediated platelet activation on the release of VEGF and endostatin from platelets.

Authors:  Nadia M Bambace; Jamie E Levis; Chris E Holmes
Journal:  Platelets       Date:  2010       Impact factor: 3.862

6.  Angiogenic properties of sustained release platelet-rich plasma: characterization in-vitro and in the ischemic hind limb of the mouse.

Authors:  Shyamal Chandra Bir; Jiro Esaki; Akira Marui; Kenichi Yamahara; Hideki Tsubota; Tadashi Ikeda; Ryuzo Sakata
Journal:  J Vasc Surg       Date:  2009-08-12       Impact factor: 4.268

7.  Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count.

Authors:  Gernot Weibrich; Wilfried K G Kleis; Gerd Hafner; Walter E Hitzler
Journal:  J Craniomaxillofac Surg       Date:  2002-04       Impact factor: 2.078

8.  TGF-beta 1 induced fibroblast proliferation is mediated by the FGF-2/ERK pathway.

Authors:  Li Xiao; Yan Du; Yang Shen; Ying He; Hui Zhao; Zhenhua Li
Journal:  Front Biosci (Landmark Ed)       Date:  2012-06-01

9.  Does platelet-rich plasma freeze-thawing influence growth factor release and their effects on chondrocytes and synoviocytes?

Authors:  Alice Roffi; Giuseppe Filardo; Elisa Assirelli; Carola Cavallo; Annarita Cenacchi; Andrea Facchini; Brunella Grigolo; Elizaveta Kon; Erminia Mariani; Loredana Pratelli; Lia Pulsatelli; Maurilio Marcacci
Journal:  Biomed Res Int       Date:  2014-07-17       Impact factor: 3.411

10.  Serum-dependence of affinity-mediated VEGF release from biomimetic microspheres.

Authors:  David G Belair; Andrew S Khalil; Michael J Miller; William L Murphy
Journal:  Biomacromolecules       Date:  2014-05-12       Impact factor: 6.988

View more
  2 in total

1.  Src family kinases inhibition by dasatinib blocks initial and subsequent platelet deposition on collagen under flow, but lacks efficacy with thrombin generation.

Authors:  Yiyuan Zhang; Scott L Diamond
Journal:  Thromb Res       Date:  2020-05-13       Impact factor: 3.944

2.  Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Branch Retinal Vein Occlusion.

Authors:  Dan-Dan Zhu; Xun Liu
Journal:  J Ophthalmol       Date:  2019-10-31       Impact factor: 1.909

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.